Medication, Medication Management
The Role of Pharmacoeconomics in Decision Making at the Institutional Level for Speciality Drugs
Pharmacoeconomics has been used, in various ways, at the institutional level, for formulary decision making around specialty pharmaceuticals. This program reviews the role of pharmacoeconomics and cost-effectiveness thresholds, along with mechanisms that influence and affect drug policy listing decisions.
DURATION
20 min
PROFESSION
Pharmacy
# OF CREDITS
0.5
ACCREDITATION
CCCEP
EXPIRY DATE
2024-03-10
Pharmacoeconomics has been used, in various ways, at the institutional level, for formulary decision making around specialty pharmaceuticals. This program reviews the role of pharmacoeconomics and cost-effectiveness thresholds, along with mechanisms that influence and affect drug policy listing decisions.
This program is supported by Pharmascience
Faculty
Ahmad Abulaban, MBBS, SBN, CRND, MSCS, ABCN (CCEEG)
Assistant Professor of Neurology
King Saud bin-Abdulaziz University for Health Sciences
Neurology Consultant
Division of Neurology, Department of Medicine
King Abdulaziz Medical City, National Guard Health Affairs
Yaser M. Al Malik, MD, FRCPC, American Board of Psychiatry and Neurology, CSCN (EEG & EMG)
Assistant professor and Consultant Neurologist
King Saud bin Abdulaziz University for Health Sciences
King Abdulaziz Medical City, Ministry of National Guard Health Affairs
Moe Abdallah, B.SC., B.SC.PHM., R.PH
Clinical pharmacist, Drug Programs Policy and Strategy Branch
Ontario Public Drug Programs
Ministry of Health and Long-Term Care
Michael Boivin, RPh, BScPhm
Clinical Pharmacist Consultant and Continuing Education Developer
Learning objectives
After viewing this expert brief, participants will be better able to:
- Describe how pharmacoeconomics is used to make listing decisions at the hospital /institutional level
- Explain how cost-effectiveness thresholds inform drug policy listing decisions
- Discuss the role of private listing agreements